Viewing nowDonepezil Tablets 10 mg (Donepezil Hydrochloride Monohydrate)
Donepezil Hydrochloride Hydrate 10mg
Tablet · Prescription medication
Hawon Pharmaceutical Co., Ltd.

MFDS item code 201603160 · Approved 2016.06.01 · Insurance code 651503790
Treatment of symptoms of Alzheimer-type dementia
This medication is used to slow the progression of symptoms of Alzheimer's disease and to improve memory and cognitive function.
Adults: Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, taking this medicine in the morning may be considered. Since donepezil concentrations reach steady state 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose escalation, administer a dose of 5 mg for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg once daily, administer with attention to gastrointestinal adverse reactions. If this medicine is discontinued, its effects gradually decrease, and no rebound effect occurs following abrupt discontinuation. Female patients aged 85 years or older with low body weight: Careful monitoring is required because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg once daily.
Children: There is no experience with use in children.
This medication contains donepezil hydrochloride as its main ingredient and is used to treat symptoms of Alzheimer's disease. This medication should not be administered to patients who are allergic to donepezil hydrochloride, piperidine derivatives, or any other components of this medication. Women who are pregnant or may become pregnant and nursing mothers should also not take this medication. Since it contains lactose, patients with hereditary disorders such as lactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medication. Caution should be exercised in patients with heart disease, particularly those with sick sinus syndrome or atrioventricular block, as this medication can stimulate the vagus nerve, potentially causing bradycardia or arrhythmias. Patients taking non-steroidal anti-inflammatory drugs or with a history of peptic ulcers should be cautious due to the risk of increased gastric secretion and gastrointestinal motility, which may exacerbate ulcers. Patients with a history of asthma or obstructive pulmonary disease should be careful, as this medication can contract bronchial smooth muscle and increase mucus secretion, worsening symptoms. Patients with extrapyramidal disorders such as Parkinson's disease should also be cautious, as this medication may worsen their symptoms. Additionally, individuals allergic to the color additive Yellow No. 5 should be administered this medication with caution. While taking this medication, symptoms related to heart abnormalities such as syncope, bradycardia, heart block, QT interval prolongation, myocardial infarction, and heart failure may occur; if these symptoms arise, the medication should be discontinued immediately and medical advice should be sought. Serious side effects such as peptic ulcers, gastrointestinal bleeding, hepatitis, liver dysfunction, cerebral seizures, symptoms of extrapyramidal disorders, neuroleptic malignant syndrome, rhabdomyolysis, respiratory distress, acute pancreatitis, acute renal failure, and sudden death of unknown cause have also been reported, necessitating caution. Commonly, side effects such as diarrhea, nausea, vomiting, dizziness, insomnia, headache, loss of appetite, fatigue, muscle pain, rash, urinary incontinence may occur. These side effects are generally mild and transient; however, if symptoms are severe or persistent, consultation with a physician is advised. This medication is not approved for other forms of dementia or age-related cognitive decline, thus it should only be used in patients diagnosed with Alzheimer's disease. Monitoring by a specialist is required during the initiation and maintenance of therapy, and caregivers should regularly observe the drug administration status. Patients with heart disease or electrolyte abnormalities, as well as those with a history of QT interval prolongation, may require an electrocardiogram during treatment with this medication due to the risk of cardiac arrhythmias. Since this medication may affect driving or operation of machinery, caution is advised if dizziness or fatigue is experienced after taking this medication. This medication may interact with other drugs; therefore, it is essential to discuss with a physician or pharmacist, particularly when taking medications that affect CYP3A4 and CYP2D6 enzymes, muscle relaxants, cholinergic agents, anticholinergic agents, beta-blockers, and NSAIDs. Women who are pregnant or nursing should avoid using this medication and should consult a specialist before use, even when absolutely necessary. Safety for pediatric patients has not been established, so it is not administered to children. In case of overdose, symptoms may include nausea, vomiting, bradycardia, hypotension, respiratory depression, seizures, and immediate medical attention is required, where atropine or other antidotes may be administered. This medication should be stored out of reach of children and not transferred to another container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture ingress, and kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness for a long time.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 10mg
Tablet · Prescription medication
Hawon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.